欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5871/001
药品名称Enzalutamide CF 40 mg, Film-coated tablets
活性成分
    • enzalutamide 40.0 mg
剂型Film-coated tablet
上市许可持有人Centrafarm B.V. van de Reijtstraat 31-E, 4814 NE Breda, The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Enzalutamide PharOS 40 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Portugal (PT)
    • Czechia (CZ)
      Enzalutamide PharOS
    • Italy (IT)
    • Romania (RO)
      Enzalutamidă PharOS 40 mg comprimate filmate
    • Greece (GR)
    • Slovakia (SK)
    • Germany (DE)
      Enzalutamide PharOS 40 mg Filmtabletten
    • Sweden (SE)
    • Slovenia (SI)
    • Denmark (DK)
      Enzalutamide STADA
    • Norway (NO)
    • Malta (MT)
      Enzalutamide PharOS 40 mg film-coated tablets
    • Belgium (BE)
      Enzalutamide EG 40 mg filmomhulde tabletten
    • Finland (FI)
      Enzalutamide PharOS
    • Croatia (HR)
    • Luxembourg (LU)
    • Poland (PL)
      Enzalutamide Stada
    • Iceland (IS)
    • Latvia (LV)
    • Ireland (IE)
    • Lithuania (LT)
      Enzalutamide STADA 40 mg plėvele dengtos tabletės
    • Austria (AT)
    • Estonia (EE)
    • France (FR)
    • Hungary (HU)
      Enzalutamide Stada 40 mg filmtabletta
    • Spain (ES)
    • Cyprus (CY)
      Enzalutamide PharOS 40 mg επικαλυμμένα με λεπτό υμένιο δισκία
许可日期2024/05/28
最近更新日期2024/11/12
药物ATC编码
    • L02BB04 enzalutamide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase